title: Tuberculous liver abscess treated by percutaneous infusion of antituberculous agents.
abstract: Tuberculous liver abscess has been reported in only fourteen patients in Japan and in twenty-nine patients outside Japan. Only nine of the non-Japanese patients and none of the Japanese patients have been treated for this condition without laparotomy. We report a patient who developed tuberculous liver abscess during treatment of tuberculous peritonitis. Diagnosis was made by ultrasound-guided aspiration biopsy, and the patient was treated with percutaneous drainage and transcatheter infusion of antituberculous agents. Direct infusion of antituberculous agents has more direct effects in the treatment of an abscess than systemic chemotherapy alone. Therefore, if a percutaneous catheter can be safely placed, the use of transcatheter infusion of antituberculous agents should be considered.
authors.affiliation: Department of Internal Medicine, Miyazaki Prefectural Nichinan Hospital.
authors.forename: H
authors.initials: H
authors.lastname: Kubota
authors.forename: M
authors.initials: M
authors.lastname: Ageta
authors.forename: H
authors.initials: H
authors.lastname: Kubo
authors.forename: S
authors.initials: S
authors.lastname: Wada
authors.forename: S
authors.initials: S
authors.lastname: Nagamachi
authors.forename: T
authors.initials: T
authors.lastname: Yamanaka
mesh_terms: D000279:Administration, Cutaneous; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008100:Liver Abscess / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D014395:Peritonitis, Tuberculous / Q000150:complications* / Q000188:drug therapy; D012293:Rifampin / Q000627:therapeutic use; D014386:Tuberculosis, Hepatic / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000995:Antitubercular Agents; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin